Vapers Digest 3rd March
Monday’s News at a glance:
Bulgaria Bans Vapes ~ A full guide to vape aerosols, formation, properties and comparisons: Post 3. ~ High-Smoking France Bans Disposable Vapes and Nicotine Pouches ~ Our vaping delusions have gone up in smoke. The Kiwis have a better idea ~ 10-Year Milestones ~ France bans nicotine pouches despite being promising smoking quitting aid ~ Sweden’s success in nicotine pouch regulations: lessons for the EU ~ Media Watch: Taz.de Exposes Its Illiberalism With Article on Nicotine Pouches ~ Considerate Pouchers and allies in UK Harm reduction have objected to proposed laws in Denmark limiting the strength of nicotine pouches to 9mgs ~ Will Martin Makary’s FDA listen to the evidence on e-cigarettes? ~ Tobacco Harm Reduction in President Trump’s Second Term: Opportunities and Challenges ~ Let’s talk e-cigarettes, February 2025 ~ BELGIUM BANS DISPOSABLES! | Featuring Alberto Gómez Hernández
Bulgaria Bans Vapes
Dave Cross, Planet of the Vapes
The World Vapers’ Alliance (WVA) has strongly criticized the Bulgarian Parliament’s recent unanimous vote to implement a blanket ban on vaping products. The organisation says that this “ill-conceived decision threatens public health and ignores scientific evidence supporting vaping as a less harmful alternative to smoking”.
A look back at how things have moved on or otherwise…
Martin McKee: Still wrong about vaping
Christopher Snowdon, Velvet Glove Iron Fist
The heavily overweight Zero Covid crank Martin McKee had a letter published in The Times yesterday in response to an op-ed from the paper’s resident puritan Alice Thomson (whom we have come across before). Thomson has spotted a real problem – the sharp rise in vaping among teenagers, especially those using Elf bars – but characteristically comes up with the wrong solutions: banning flavours, banning colours and getting Public Health England (which she thinks still exists) to “treat vaping in the same way as cigarettes”.
Exposing Defective Research…
But Denied Credit for the Effort: Case 2
Brad Rodu, Tobacco Truth
Two weeks ago I described a flawed mortality study by National Cancer Institute staff that led to a correction but no recognition for our group’s work in uncovering the errors. Here we detail a second, similar case, involving a vaping study by faculty at Columbia and the University of Arkansas, including a former member of the FDA Tobacco Products Scientific Advisory Committee (TPSAC).
Visit Nicotine Science & Policy for more News from around the World
